Lois E. Shepherd
- Oncology top 0.1%
- Cancer Treatment and Pharmacology 29
- HER2/EGFR in Cancer Research 23
- Cancer Risks and Factors 14
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 51
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment 38
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments 14
- Genetics top 0.5%
- Estrogen and related hormone effects 41
- Chronic Lymphocytic Leukemia Research 14
- Co-authors
- Dongsheng TuKathleen I. PritchardMalcolm J. MooreDaniel J. SargentRichard M. GoldbergCharles A. SchifferHaji ChalchalFrederick R. Appelbaum
- Journals
- Journal of Clinical Oncology (54 papers)Blood (21 papers)Breast Cancer Research and Treatment (18 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Lois E. Shepherd
197 papers receiving 15.5k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Oncology 9.9k
- Cancer Research 4.5k
- Pathology and Forensic Medicine 5.1k
- Hematology 1.4k
- Genetics 1.3k
Countries citing papers authored by Lois E. Shepherd
This map shows the geographic impact of Lois E. Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois E. Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois E. Shepherd more than expected).
Fields of papers citing papers by Lois E. Shepherd
This network shows the impact of papers produced by Lois E. Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois E. Shepherd. The network helps show where Lois E. Shepherd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lois E. Shepherd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 1 | |
| 4 | 2021 | 7 | |
| 5 | 2021 | 12 | |
| 6 | 2020 | 22 | |
| 7 | 2017 | 1 | |
| 8 | 2017 | 11 | |
| 9 | 2017 | 19 | |
| 10 | 2016 | 43 | |
| 11 | 2016 | 0 | |
| 12 | 2015 | 28 | |
| 13 | 2014 | 37 | |
| 14 | 2013 | 153 | |
| 15 | 2012 | 220 | |
| 16 | 2012 | 105 | |
| 17 | 2011 | 16 | |
| 18 | 2005 | 203 | |
| 19 | Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemiabreakdown → | 2000 | 754 |
| 20 | 1985 | 6 |
About Lois E. Shepherd
Lois E. Shepherd is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 204 papers that have together received 15.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (51 papers), Estrogen and related hormone effects (41 papers), Lymphoma Diagnosis and Treatment (38 papers), Cancer Treatment and Pharmacology (29 papers), HER2/EGFR in Cancer Research (23 papers), Chronic Lymphocytic Leukemia Research (14 papers), Cancer Risks and Factors (14 papers) and Multiple Myeloma Research and Treatments (14 papers). The work is most often cited by research in Oncology (9.9k citations), Cancer Research (4.5k citations) and Pathology and Forensic Medicine (5.1k citations). Lois E. Shepherd has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Dongsheng Tu, Kathleen I. Pritchard, Malcolm J. Moore, Daniel J. Sargent, Richard M. Goldberg, Charles A. Schiffer, Haji Chalchal, Frederick R. Appelbaum, James N. Ingle and Timothy Price. Their work appears in journals such as Journal of Clinical Oncology, Blood, Breast Cancer Research and Treatment, Annals of Oncology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.